Tensys Medical, Inc., a leader in the development and commercialization of continuous, non-invasive hemodynamic patient monitoring systems, has entered into a commercial agreement with Zhejiang Shanshi Medical Device CO., LTD (Shanshi) for distribution of the company’s T-Line technology.
Researchers from the Universitat Autònoma de Barcelona (UAB), led by Fàtima Bosch, have shown for the first time that it is possible to cure diabetes in large animals with a single session of gene therapy. As published this week in Diabetes, the principal journal for research on the disease, after a single gene therapy session, the dogs recover their health and no longer show symptoms of the disease. In some cases, monitoring continued for over four years, with no recurrence of symptoms.
Pepex Biomedical, Inc. announced today it will enter the mHealth arena by incorporating Machine-to-Machine (M2M) network capabilities in all of its diagnostic medical devices reflecting the company's confidence in the underlying proprietary technology. Pepex will begin with the Trio™ line of blood glucose devices and sees M2M as an ideal wireless diabetes care solution that can bridge the current generation of smartphone based health apps to become a true wireless monitoring solution for diabetes.
Awarepoint Corporation, the largest real-time location system (RTLS) corporation dedicated exclusively to healthcare, announces the launch of its new Bed and Bay Sensor that enables precise tracking of mobile equipment and patient and caregiver interactions in locations with tight-bed spacing, such as the emergency department (ED) and pre- and post-anesthesia care.
Adults living with diabetes in the United States reported highest satisfaction using Roche Diabetes Care's ACCU-CHEK products compared with other blood glucose meter manufacturers, according to the inaugural J.D. Power and Associates 2012 Blood Glucose Meter Satisfaction StudySM. Diabetes affects a large portion of the U.S. population – 25.8 million children and adults or approximately 1 in 12 people.
UT Dallas researchers are extending the borders of virtual reality, going beyond virtual spaces in which people can see and hear one another to an environment that adds the sense of touch.
For years the trends have been clear: not only are we getting older all the time, but we are also increasingly left to take care of ourselves in our old age. This is why researchers are already working on technologies that will assist us in everyday situations later in life. One of these technologies is will be presented by the Fraunhofer Institute for Integrated Circuits IIS in Erlangen (Germany) at the CeBIT trade fair in Hanover, March 5-9, 2013 (Hall 9, stand E08): an intelligent armchair we can not only comfortably sink into in front of the television but one that also motivates us to keep ourselves healthy and fit.
Three teams, including the first all-undergraduate team to place, earned a total of $140,000 during the annual Olin Cup commercial business plan competition finals Jan. 30 in Simon Hall.
On the tails of CES, global media communications agency Havas Media released today a video exploring one of the hottest trends for consumers and marketers today: Life Tracking and the Quantified Self. Through today's technologies, life tracking allows people to measure and monitor the activities in their daily lives, from eating and sleeping to exercising and shopping.
Breezing, a new startup based on technology developed by researchers at Arizona State University, is offering the world's first portable device that can track an individual's metabolism and use that information to provide diet and exercise recommendations for maintaining or reaching a healthy weight.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.